Skip to main content
. 2025 May 7;17(9):1587. doi: 10.3390/cancers17091587
AIPaSiM Associazione italiana pazienti sindromi mielodisplastica
alloHSCT allogeneic hematopoietic stem cell transplantation
HM-PRO hematological malignancy-patient-reported outcomes
HRQoL health-related quality of life
HSTC hematopoietic stem cell transplantation
IPSS-R Revised International Prognostic Scoring System
IQR interquartile range
MDS myelodysplastic neoplasms
MDSS MDS-specific
PRO patient-reported outcome
PROM PRO measure
QOL-E HRQoL instrument developed specifically for MDS patients